Rossiiskii immunologicheskii zhurnalIssue 4Spectrum of Immunobiological Activity and Potential of Practical Application of Synthetic Peptid the Active Centre of Granulocyte-macrophage Colony-stimulating Factor (GM-CSF)
views: 1219
Readers community rating: votes 0
1. Ketlinskij S. A., Simbirtsev A. S. Tsitokiny. – SPb.: Foliant, 2008. – 552 s. [Ketlinsky S. A., Simbircev A. S. Cytokins. – SPb.: Volume, 2008. – 552 p.].
2. Kozlov V. A., Borisov A. G., Smirnova S. V., Savchenko A. A. Prakticheskie aspekty diagnostiki i lecheniya immunnykh narushenij: Rukovodstvo dlya vrachej. – Novosibirsk: Nauka, 2009. – 274 s. [Kozlov V. A., Borisov A. G., Smirnova S. V., Savchenko A. A. Practical aspects of diagnostics and treatment of immune violations: The management for doctors. – Novosibirsk: Science, 2009. – 274 p.].
3. Cruz A. F., Santelises M. A., Espinosa O. R., Espinosa D. M., Castillo B. M., Payan J. B., Pando R. H. Granu locyte-macrophage colony-stimulating factor: not just another haematopoietic growth factor. // Med. Oncol. –2014. – № 31. – P. 774–788.
4. Van Nieuwenhuij ze A., Koenders M., Roeleveld D., Sleeman M. A., Van den Bergb W., Wicks I. P. GM-CSF as a therapeutic target in infl ammatory diseases. // Molecular Immunology. – 2013. – № 56. – P. 675–682.
5. Zurochka A. V., Zurochka V. A., Sukhovej Yu. G., Dobrynina M. A., Kostolomova E. G., Gritsenko V. A., Studenikina Yu. N. Immunotropnye i biologicheskie ehffekty sinteticheskikh peptidov aktivnogo tsentra GM-KSF. // Vestnik ural'skoj meditsinskoj akademicheskoj nauki. – 2011. – № 2/2 (35). – S. 23–24. [Zurochka A. V., Zurochka V. A., Suchovei Yu. G., Dobrynin M. A., Kostolomova E. G., Gritsenko V. A., Studenikina Yu. N. Immunotropic and biological eff ects of synthetic peptides of the GM-CSF active center.// Messenger of the Ural medical academic science. – 2011. – No. 2/2 (35). – P. 23–24].
6. Zurochka A. V., Zurochka V. A., Dobrynina M. A., Zueva E. B., Gol'tsova I. A., Gritsenko V. A. Novye podkhody k izucheniyu spektra biologicheskoj aktivnosti sinteticheskikh peptidov aktivnogo tsentra GM-KSF. // Rossijskij immunologicheskij zhurnal. – 2014. – T. 8 (17), № 3. – S. 690–693. [Zurochka A. V., Zurochka V. A., Dobrynina M. A., Zuyeva E. B., Goltsova I. A., Gritsenko V. A. New approaches to studying of a range of biological activity of synthetic peptides of the GM-KSF active center.// Russian journal of immunology. – 2014. – T. 8 (17), No. 3. – P. 690–693].
7. Zurochka A. V., Zurochka V. A., Kostolomova E. G. i dr. Sravnitel'naya kharakteristika antibakterial'nykh svojstv sinteticheskikh peptidov aktivnogo tsentra GM-CSF i veschestv, poluchennykh iz supernatantov CD34+CD45dim kletok-pred shestven nikov gemopoehza. // Tsitokiny i vospalenie. – 2012. – T. 11, № 2. – S. 96–99. [Zurochka A. V., Zurochka V. A., Kostolomova E. G., et al. The comparative characteristic of antibacterial properties of synthetic peptides of the active center GM-CSF and the substances received from supernatant of CD34+CD45dim of cages predecessors of a gemopoez.//Cytokines and infl ammation. – 2012. – T. 11, No. 2. – P. 96–99.
8. Gritsenko V. A., Aminin D. L., Zurochka A. V., Zurochka V. A., Ivanov Yu. B. Nekotorye biologicheskie ehffekty immonomodulyatorov estestvennogo i sinteticheskogo proiskhozhdeniya in vitro kak osnova sozdaniya novykh lekarstvennykh sredstv dlya bor'by s ehndogennymi infektsiyami. // Byulleten' Orenburgskogo nauchnogo tsentra UrO RAN. – 2012. – № 3. – 17 s. [Ehlektronnyj resurs]. (URL: http://elmag.uran.ru:9673/magazine/Numbers/ 2012–3/Articles/15GricenkoVA-ADL-ZAV.pdf).[Gritsenko V. A., Aminind.L., Zurochka A. V., Zurochka V. A., Ivanov Yu. B. Some biological eff ects of immonomodulyator of a natural and synthetic origin of in vitro as basis of creation of new medicines for fi ght against endogenous infections. // Bulletin of Orenburg scientifi c centerUrB RAS. 2012. 3:17 r. [An electronic resource]. (URL: http://elmag.uran.ru:9673/magazine/Numbers/2012–3/Articles/ 15GricenkoVA-ADL-ZAV.pdf).
